Logo image of OWLT

OWLET INC (OWLT) Stock Fundamental Analysis

NYSE:OWLT - US69120X2062 - Common Stock

6.92 USD
-0.29 (-4.02%)
Last: 8/28/2025, 8:04:01 PM
6.92 USD
0 (0%)
After Hours: 8/28/2025, 8:04:01 PM
Fundamental Rating

2

OWLT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of OWLT have multiple concerns. OWLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OWLT had negative earnings in the past year.
In the past year OWLT has reported a negative cash flow from operations.
OWLT had negative earnings in each of the past 5 years.
OWLT had a negative operating cash flow in each of the past 5 years.
OWLT Yearly Net Income VS EBIT VS OCF VS FCFOWLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of OWLT (-30.18%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROIC N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OWLT Yearly ROA, ROE, ROICOWLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

OWLT's Gross Margin of 51.06% is in line compared to the rest of the industry. OWLT outperforms 43.78% of its industry peers.
In the last couple of years the Gross Margin of OWLT has grown nicely.
OWLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
OWLT Yearly Profit, Operating, Gross MarginsOWLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

OWLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
OWLT has more shares outstanding than it did 1 year ago.
OWLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OWLT has been reduced compared to a year ago.
OWLT Yearly Shares OutstandingOWLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
OWLT Yearly Total Debt VS Total AssetsOWLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

OWLT has an Altman-Z score of -5.47. This is a bad value and indicates that OWLT is not financially healthy and even has some risk of bankruptcy.
OWLT's Altman-Z score of -5.47 is on the low side compared to the rest of the industry. OWLT is outperformed by 70.81% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.47
ROIC/WACCN/A
WACC10.41%
OWLT Yearly LT Debt VS Equity VS FCFOWLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

2.3 Liquidity

A Current Ratio of 1.19 indicates that OWLT should not have too much problems paying its short term obligations.
OWLT has a worse Current ratio (1.19) than 83.78% of its industry peers.
OWLT has a Quick Ratio of 1.19. This is a bad value and indicates that OWLT is not financially healthy enough and could expect problems in meeting its short term obligations.
OWLT's Quick ratio of 0.90 is on the low side compared to the rest of the industry. OWLT is outperformed by 83.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.9
OWLT Yearly Current Assets VS Current LiabilitesOWLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.78% over the past year.
OWLT shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.52%.
OWLT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.40% yearly.
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.52%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%26.09%

3.2 Future

The Earnings Per Share is expected to grow by 29.12% on average over the next years. This is a very strong growth
OWLT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.04% yearly.
EPS Next Y-86.21%
EPS Next 2Y5.94%
EPS Next 3Y26.98%
EPS Next 5Y29.12%
Revenue Next Year32.11%
Revenue Next 2Y27.41%
Revenue Next 3Y24.75%
Revenue Next 5Y28.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OWLT Yearly Revenue VS EstimatesOWLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
OWLT Yearly EPS VS EstimatesOWLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OWLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OWLT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OWLT Price Earnings VS Forward Price EarningsOWLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OWLT Per share dataOWLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as OWLT's earnings are expected to grow with 26.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.94%
EPS Next 3Y26.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OWLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OWLET INC

NYSE:OWLT (8/28/2025, 8:04:01 PM)

After market: 6.92 0 (0%)

6.92

-0.29 (-4.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners50.55%
Inst Owner Change10.12%
Ins Owners6.03%
Ins Owner Change-0.12%
Market Cap117.92M
Analysts82
Price Target13.46 (94.51%)
Short Float %3.02%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)80.78%
Min EPS beat(2)74.89%
Max EPS beat(2)86.67%
EPS beat(4)4
Avg EPS beat(4)93.46%
Min EPS beat(4)74.89%
Max EPS beat(4)112.26%
EPS beat(8)4
Avg EPS beat(8)-16.31%
EPS beat(12)7
Avg EPS beat(12)-8.05%
EPS beat(16)7
Avg EPS beat(16)-20.76%
Revenue beat(2)2
Avg Revenue beat(2)15.76%
Min Revenue beat(2)14.05%
Max Revenue beat(2)17.47%
Revenue beat(4)3
Avg Revenue beat(4)9.39%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)17.47%
Revenue beat(8)3
Avg Revenue beat(8)-4.11%
Revenue beat(12)3
Avg Revenue beat(12)-5.92%
Revenue beat(16)5
Avg Revenue beat(16)-11.69%
PT rev (1m)11.55%
PT rev (3m)29.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.79%
EPS NY rev (1m)-8.03%
EPS NY rev (3m)-23.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)5.74%
Revenue NY rev (3m)7.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS5.82
BVpS-0.7
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.06%
FCFM N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
F-Score5
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.54%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.9
Altman-Z -5.47
F-Score5
WACC10.41%
ROIC/WACCN/A
Cap/Depr(3y)56.11%
Cap/Depr(5y)93.79%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-86.21%
EPS Next 2Y5.94%
EPS Next 3Y26.98%
EPS Next 5Y29.12%
Revenue 1Y (TTM)44.52%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%26.09%
Revenue Next Year32.11%
Revenue Next 2Y27.41%
Revenue Next 3Y24.75%
Revenue Next 5Y28.04%
EBIT growth 1Y2.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year106.5%
EBIT Next 3Y41.73%
EBIT Next 5Y31.23%
FCF growth 1Y77.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.22%
OCF growth 3YN/A
OCF growth 5YN/A